Mouse Intratongue Injection With Cancer Cells—An Orthotopic Model for Head and Neck Squamous Cell Carcinoma
5 affiliations
- 1Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland
- 2Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland
- 3Turku Collegium for Science, Medicine and Technology (TCSMT), Turku, Finland
- 4InFLAMES Research Flagship Center, University of Turku and Åbo Akademi University, Turku, Finland
- 5Foundation for the Finnish Cancer Institute, Tukholmankatu 8, FI-00014 Helsinki, Finland
Abstract
Syngeneic and orthotopic injection of cancer cells in mice is a gold standard model in pre-clinical cancer research. Herein, we detail a protocol of orthotopic intratongue injection as a model for upper respiratory tract cancer studies. This model recapitulates tumor growth and invasion in an orthotopic site, the oral cavity mucosa. It can be experimentally designed in a syngeneic context or used to study patient-derived cells in immunocompromised animals. Procedurally, mice are anesthetized and injected with a small volume of cancer cell suspension near the lateral border of the tongue, right under the mucous membrane. Post-injection, animal welfare is carefully attended to by appropriate analgesia, while providing soft food for the duration of the experiment to ensure the ability of the mice to eat ad libitum. Tongues and potential metastatic organs are dissected and can be sampled and analyzed using relevant state-of-the-art methods, including -omics and imaging approaches. We describe a broad range of distinct tumor profiling and analysis methods applicable to this model. These include physical measurements of elasticity with atomic force microscopy on fresh tissue, hematoxylin-eosin staining and standard immunohistochemistry, and confocal microscopy applied to paraffin-embedded tongue sections. This model is orthotopic, accessible without surgery, easy to monitor, and rapid to perform.
Key features
• Orthotopic and clinically relevant head and neck squamous cell carcinoma (HNSCC) model.
• Rapid, reproducible, and minimally invasive procedure.
• Compatible with multimodal downstream analyses.
• Versatile platform for preclinical studies.
Related
- GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: Different pattern of squamous cell carcinoma and adenocarcinoma
- Advances in Treatment of Refractory Advanced and Recurrent Cervical Adenocarcinoma: Molecular Heterogeneity and Differences from Squamous Cell Carcinoma
- Inhibitory Mechanism of Bee Venom Against A431 Cutaneous Squamous Cell Carcinoma Cells Based on Label-Free Proteomics and Untargeted Metabolomics
- Saliva-based genomic signatures for early detection of oral squamous cell carcinoma: the state and perspectives of translation
- Multiomics analysis reveals the enhancer landscapes and 3D chromatin architecture in esophageal squamous cell carcinoma
BibTeX
@article{follain2026mouse,
title = {{Mouse Intratongue Injection With Cancer Cells—An Orthotopic Model for Head and Neck Squamous Cell Carcinoma}},
author = {Gautier Follain and Jasmin Kaivola and Omkar Joshi and Mathilde Mathieu and Johanna Ivaska},
journal = {Bio-protocol},
year = {2026},
month = nov,
doi = {10.21769/bioprotoc.5861},
url = {https://doi.org/10.21769/bioprotoc.5861},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Mouse Intratongue Injection With Cancer Cells—An Orthotopic Model for Head and Neck Squamous Cell Carcinoma
AU - Gautier Follain
AU - Jasmin Kaivola
AU - Omkar Joshi
AU - Mathilde Mathieu
AU - Johanna Ivaska
PY - 2026
DA - 2026/11/05
JO - Bio-protocol
DO - 10.21769/bioprotoc.5861
UR - https://doi.org/10.21769/bioprotoc.5861
AB - Syngeneic and orthotopic injection of cancer cells in mice is a gold standard model in pre-clinical cancer research. Herein, we detail a protocol of orthotopic intratongue injection as a model for upper respiratory tract cancer studies. This model recapitulates tumor growth and invasion in an orthotopic site, the oral cavity mucosa. It can be experimentally designed in a syngeneic context or used to study patient-derived cells in immunocompromised animals. Procedurally, mice are anesthetized and injected with a small volume of cancer cell suspension near the lateral border of the tongue, right under the mucous membrane. Post-injection, animal welfare is carefully attended to by appropriate analgesia, while providing soft food for the duration of the experiment to ensure the ability of the mice to eat ad libitum. Tongues and potential metastatic organs are dissected and can be sampled and analyzed using relevant state-of-the-art methods, including -omics and imaging approaches. We describe a broad range of distinct tumor profiling and analysis methods applicable to this model. These include physical measurements of elasticity with atomic force microscopy on fresh tissue, hematoxylin-eosin staining and standard immunohistochemistry, and confocal microscopy applied to paraffin-embedded tongue sections. This model is orthotopic, accessible without surgery, easy to monitor, and rapid to perform. Key features • Orthotopic and clinically relevant head and neck squamous cell carcinoma (HNSCC) model. • Rapid, reproducible, and minimally invasive procedure. • Compatible with multimodal downstream analyses. • Versatile platform for preclinical studies.
SN - 2331-8325
ER -